Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

Evaluation of adult dTPaP vaccination coverage in France: experience in Lyon city, 2010-2011.

Baratin D, Del Signore C, Thierry J, Caulin E, Vanhems P.

BMC Public Health. 2012 Nov 1;12:940. doi: 10.1186/1471-2458-12-940.

PMID:
23114050
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Vaccination against tetanus, diphtheria, pertussis and poliomyelitis in adult travellers.

Gautret P, Wilder-Smith A.

Travel Med Infect Dis. 2010 May;8(3):155-60. doi: 10.1016/j.tmaid.2010.02.007. Epub 2010 Mar 19. Review.

PMID:
20541135
[PubMed - indexed for MEDLINE]
3.

Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.

Grimprel E, von Sonnenburg F, Sänger R, Abitbol V, Wolter JM, Schuerman LM.

Vaccine. 2005 May 25;23(28):3657-67.

PMID:
15882526
[PubMed - indexed for MEDLINE]
4.

Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.

Larnaudie S, Guiso N, Baptiste C, Desaint C, Desforges L, Lebon P, Soubeyrand B, Launay O.

Hum Vaccin. 2010 Oct;6(10):829-34. doi: 10.4161/hv.6.10.12582. Epub 2010 Oct 1.

PMID:
20864810
[PubMed - indexed for MEDLINE]
Free Article
5.

Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.

Lee SY, Hwang HS, Kim JH, Kim HH, Lee HS, Chung EH, Park SE, Ma SH, Chang JK, Guitton F, Ortiz E, Kang JH.

Vaccine. 2011 Feb 11;29(8):1551-7. doi: 10.1016/j.vaccine.2010.12.094. Epub 2011 Jan 6.

PMID:
21215828
[PubMed - indexed for MEDLINE]
6.
7.

[Regional variations of adult population vaccinal status].

Beytout J, Denis F, Giet R, Allaert FA.

Med Mal Infect. 2004 Oct;34(10):460-8. French.

PMID:
15747471
[PubMed - indexed for MEDLINE]
8.

[Characteristics of specific immunity in children vaccinated with AKDS-vaccine at increased intervals between vaccinations].

Veĭsfeĭler OIu, Perel'shteĭn NN, Aleksina SG, Koval'skaia SIa, Braginskaia VP.

Zh Mikrobiol Epidemiol Immunobiol. 1974 Apr;51(4):36-9. Russian. No abstract available.

PMID:
4830390
[PubMed - indexed for MEDLINE]
9.

An open-label, randomized, multicenter study of the safety, tolerability, and immunogenicity of quadrivalent human papillomavirus (types 6/11/16/18) vaccine given concomitantly with diphtheria, tetanus, pertussis, and poliomyelitis vaccine in healthy adolescents 11 to 17 years of age.

Vesikari T, Van Damme P, Lindblad N, Pfletschinger U, Radley D, Ryan D, Vuocolo S, Haupt RM, Guris D.

Pediatr Infect Dis J. 2010 Apr;29(4):314-8. doi: 10.1097/INF.0b013e3181c177fb.

PMID:
19952980
[PubMed - indexed for MEDLINE]
10.

Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures. Immunization Practices Advisory Committee.

Centers for Disease Control (CDC).

MMWR Morb Mortal Wkly Rep. 1985 Jul 12;34(27):405-14, 419-26. No abstract available.

PMID:
3925316
[PubMed - indexed for MEDLINE]
11.

The value of booster vaccinations against diphtheria, tetanus, pertussis and poliomyelitis.

Gabutti G.

J Prev Med Hyg. 2008 Mar;49(1):47-54. Review. No abstract available. Erratum in: J Prev Med Hyg. 2008 Sep;49(3):124.

PMID:
18792533
[PubMed - indexed for MEDLINE]
12.

Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix(®)): results of two randomized trials.

Weston WM, Friedland LR, Wu X, Howe B.

Vaccine. 2012 Feb 21;30(9):1721-8. doi: 10.1016/j.vaccine.2011.12.055. Epub 2011 Dec 31.

PMID:
22212127
[PubMed - indexed for MEDLINE]
13.
14.

[The immunologic effectiveness of vaccination against pertussis, diphtheria and tetanus upon alteration of the scheme of its administration].

Sokhin AA, Kucheriavenko VS, Moshiazhvili IIa, Sapel'nikova LI, Arkad'eva VA.

Zh Mikrobiol Epidemiol Immunobiol. 1973 Jan;50(1):132-3. Russian. No abstract available.

PMID:
4780100
[PubMed - indexed for MEDLINE]
15.

Randomised feasibility trial of pre-exposure rabies vaccination with DTP-IPV in infants.

Lang J, Duong GH, Nguyen VG, Le TT, Nguyen CV, Kesmedjian V, Plotkin SA.

Lancet. 1997 Jun 7;349(9066):1663-5.

PMID:
9186385
[PubMed - indexed for MEDLINE]
16.

[Data on the inoculation coverage against diphtheria, pertussis and tetanus of children in the 1st 3 years of life].

Kasimova DIa, Karas' SR, Dzhavadova KM, Sadykhova SS, Nurieva LSh.

Zh Mikrobiol Epidemiol Immunobiol. 1984 Dec;(12):72-5. Russian.

PMID:
6241401
[PubMed - indexed for MEDLINE]
17.

How French physicians manage with a future change in the primary vaccination of infants against diphtheria, tetanus, pertussis and poliomyelitis? A qualitative study with focus groups.

Lungarde K, Blaizeau F, Auger-Aubin I, Floret D, Gilberg S, Jestin C, Hanslik T, Le Goaster C, Lévy-Bruhl D, Blanchon T, Rossignol L.

BMC Fam Pract. 2013 Jun 19;14:85. doi: 10.1186/1471-2296-14-85.

PMID:
23782853
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

[Epidemiologic effectiveness of adsorbed scarlatina-diphtheria-pertussis-tetanus vaccine].

Mitel'man SL, Akimova VV.

Zh Mikrobiol Epidemiol Immunobiol. 1966 Dec;43(12):15-8. Russian. No abstract available.

PMID:
6004628
[PubMed - indexed for MEDLINE]
19.

[A study of the reactogenicity and immunogenicity of sorbed pertussis-diphtheria-tetanus vaccine with lowered doses of the compounds. I. Reactogenic properties of the drug].

Tuĭmedova RA.

Zh Mikrobiol Epidemiol Immunobiol. 1969 Sep;46(9):9-13. Russian. No abstract available.

PMID:
5357671
[PubMed - indexed for MEDLINE]
20.

Extensive swelling reaction associated with diphtheria and tetanus toxoids and acellular pertussis vaccine.

Sekaran NK, Edwards KM.

Pediatr Infect Dis J. 2006 Apr;25(4):374-5.

PMID:
16567996
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk